SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
NCT06155604
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Lupus Nephritis
Chronic Kidney Diseases
Interventions
DRUG:
Dapagliflozin 10mg Tab
DRUG:
Standard maintenance therapy
Sponsor
The University of Hong Kong